The Clorox Company (NYSE:CLX) Holdings Boosted by Claro Advisors LLC

Claro Advisors LLC grew its stake in shares of The Clorox Company (NYSE:CLX) by 10.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,006 shares of the company’s stock after purchasing an additional 567 shares during the quarter. Claro Advisors LLC’s holdings in Clorox were worth $920,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Federated Hermes Inc. boosted its holdings in shares of Clorox by 16.4% during the third quarter. Federated Hermes Inc. now owns 4,744 shares of the company’s stock valued at $622,000 after acquiring an additional 670 shares during the period. Mutual Advisors LLC grew its position in Clorox by 23.2% in the 3rd quarter. Mutual Advisors LLC now owns 3,803 shares of the company’s stock worth $498,000 after purchasing an additional 717 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in shares of Clorox by 93.5% in the third quarter. Tower Research Capital LLC TRC now owns 13,793 shares of the company’s stock valued at $1,808,000 after purchasing an additional 6,663 shares during the period. Bank of Nova Scotia raised its holdings in shares of Clorox by 237.7% during the third quarter. Bank of Nova Scotia now owns 36,232 shares of the company’s stock valued at $4,749,000 after buying an additional 25,502 shares during the last quarter. Finally, Gotham Asset Management LLC boosted its position in shares of Clorox by 78.1% during the third quarter. Gotham Asset Management LLC now owns 35,939 shares of the company’s stock worth $4,710,000 after buying an additional 15,759 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of NYSE CLX opened at $134.24 on Tuesday. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.14. The stock has a market capitalization of $16.67 billion, a price-to-earnings ratio of 69.55, a PEG ratio of 2.19 and a beta of 0.39. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The stock’s fifty day simple moving average is $136.95 and its 200 day simple moving average is $143.79.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The firm had revenue of $1.81 billion for the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter last year, the business posted $1.51 EPS. Clorox’s revenue was down 5.3% on a year-over-year basis. As a group, sell-side analysts forecast that The Clorox Company will post 5.91 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts have weighed in on the company. Barclays cut their target price on Clorox from $136.00 to $132.00 and set an “underweight” rating on the stock in a research note on Thursday, May 2nd. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. BNP Paribas initiated coverage on shares of Clorox in a research note on Monday, June 24th. They set an “underperform” rating and a $130.00 target price on the stock. Citigroup reduced their price target on shares of Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Finally, Argus upgraded shares of Clorox to a “hold” rating in a research note on Tuesday, June 4th. Five investment analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $145.33.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.